RG Cooper
About
In The Last Decade
RG Cooper
47 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 422
- Epidemiology 371
- Rheumatology 371
- Genetics 254
- Immunology 229
Countries citing papers authored by RG Cooper
This map shows the geographic impact of RG Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RG Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RG Cooper more than expected).
Fields of papers citing papers by RG Cooper
This network shows the impact of papers produced by RG Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RG Cooper. The network helps show where RG Cooper may publish in the future.
Co-authorship network of co-authors of RG Cooper
This figure shows the co-authorship network connecting the top 25 collaborators of RG Cooper. A scholar is included among the top collaborators of RG Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RG Cooper. RG Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Dense Genotyping of Immune-Related Loci in the Idiopathic Inflammatory Myopathies Confirms HLA alleles as strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Annals of the Rheumatic Diseases. | 1 |
| 2 | Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 Autoantibodies. | 1 |
| 3 | Identification of autoantibodies to a novel autoantigen protein complex (EIF3) in polymyositis patients | 2 |
| 4 | 18 | |
| 5 | 28 | |
| 6 | 41 | |
| 7 | 244 | |
| 8 | The UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC): In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype rather than by myositis sub type. | 2 |
| 9 | Inter-rater reliability and validity of two disease activity assessment tools in patients with idiopathic inflammatory myositis (IIM) | 1 |
| 10 | GENETIC DIFFERENCES CAN BE DEMONSTRATED BETWEEN POLYMYOSITIS AND DERMATOMYOSITIS USING HLA-DRB1 AND DQB1 GENOTYPING | 1 |
| 11 | Development of disease activity and damage indices for myositis: Further testing of four tools in adult onset patients. | 2 |
| 12 | 89 | |
| 13 | 55 | |
| 14 | 17 | |
| 15 | 22 | |
| 16 | HLA-DP does not contribute towards SLE susceptibility | 1 |
| 17 | 11 | |
| 18 | 75 | |
| 19 | 91 | |
| 20 | 29 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.